| P50 | author | Angela Dispenzieri | Q37838558 |
| | Nelson Leung | Q42692816 |
| | Arjun Lakshman | Q47287927 |
| | Ronald S Go | Q56990716 |
| | Morie A Gertz | Q57052163 |
| | S. Vincent Rajkumar | Q61123608 |
| | David Dingli | Q66385573 |
| | Robert A Kyle | Q66385695 |
| | Martha Q Lacy | Q66419394 |
| | Wilson I Gonsalves | Q88037405 |
| | Francis K Buadi | Q88774336 |
| | John A. Lust | Q110810892 |
| | Miriam A Hobbs | Q110822873 |
| P2093 | author name string | P Kapoor | |
| | Y Lin | |
| | S J Russell | |
| | S K Kumar | |
| | S R Hayman | |
| | S R Zeldenrust | |
| | Y L Hwa | |
| | A L Fonder | |
| | T V Kourelis | |
| | M Alhaj Moustafa | |
| P2860 | cites work | Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma | Q24647620 |
| | Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group | Q28207984 |
| | Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels | Q28256986 |
| | Impact of t(11;14)(q13;q32) on the outcome of autologous hematopoietic cell transplantation in multiple myeloma. | Q34115051 |
| | International uniform response criteria for multiple myeloma. | Q34549410 |
| | Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics | Q35849219 |
| | Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma | Q35938169 |
| | Improved survival in multiple myeloma and the impact of novel therapies | Q36478461 |
| | Genetic aberrations in multiple myeloma characterized by cIg-FISH: a Brazilian context | Q36793582 |
| | Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management | Q37623809 |
| | Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. | Q37724272 |
| | Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1. | Q37835571 |
| | Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable? | Q39788992 |
| | The t(11;14)(q13;q32) translocation as a poor prognostic parameter for autologous stem cell transplantation in myeloma patients with extramedullary plasmacytoma. | Q41154238 |
| | Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma | Q41198089 |
| | Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. | Q42811937 |
| | Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma | Q44610299 |
| | Clinical and biologic implications of recurrent genomic aberrations in myeloma | Q44776402 |
| | t(11;14) multiple myeloma: a subtype associated with distinct immunological features, immunophenotypic characteristics but divergent outcome | Q46297684 |
| | Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell | Q47986862 |
| | Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 cases | Q48020548 |
| | CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma. | Q52018083 |
| | Guidelines for determination of the number of prior lines of therapy in multiple myeloma. | Q52924858 |
| | Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome. | Q53243787 |
| | Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients. | Q55035813 |
| | Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy | Q74605768 |
| | Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation | Q77725517 |
| | Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants | Q78410075 |
| | t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma | Q79087985 |
| P433 | issue | 1 | |
| P304 | page(s) | 131-138 | |
| P577 | publication date | 2017-06-27 | |
| P1433 | published in | Leukemia | Q6534498 |
| P1476 | title | Natural history of t(11;14) multiple myeloma | |
| P478 | volume | 32 | |